Getinge AB ser. B (GETI-B) - Total Assets
Based on the latest financial reports, Getinge AB ser. B (GETI-B) holds total assets worth Skr58.02 Billion SEK (≈ $6.24 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of Getinge AB ser. B to assess how comfortably operating cash covers total debt obligations.
Getinge AB ser. B - Total Assets Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Getinge AB ser. B for net asset value and shareholders' equity analysis.
Getinge AB ser. B - Asset Composition Analysis
Current Asset Composition (December 2025)
Getinge AB ser. B's total assets of Skr58.02 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr3.40 Billion | 6.0% |
| Accounts Receivable | Skr7.81 Billion | 13.8% |
| Inventory | Skr6.02 Billion | 10.7% |
| Property, Plant & Equipment | Skr4.94 Billion | 8.7% |
| Intangible Assets | Skr7.74 Billion | 13.7% |
| Goodwill | Skr25.77 Billion | 45.6% |
Asset Composition Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see GETI-B company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Getinge AB ser. B's current assets represent 30.5% of total assets in 2025, a decrease from 51.2% in 2002.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, up from 4.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 29.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 45.6% of total assets.
Getinge AB ser. B Competitors by Total Assets
Key competitors of Getinge AB ser. B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Getinge AB ser. B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.35 | 1.31 | 6.69 |
| Quick Ratio | 0.84 | 0.83 | 4.37 |
| Cash Ratio | 0.00 | 0.30 | 1.66 |
| Working Capital | Skr4.51 Billion | Skr4.28 Billion | Skr11.91 Billion |
Getinge AB ser. B - Advanced Valuation Insights
This section examines the relationship between Getinge AB ser. B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -11.6% |
| Total Assets | Skr56.51 Billion |
| Market Capitalization | $6.56 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Getinge AB ser. B's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Getinge AB ser. B's assets decreased by 11.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Getinge AB ser. B (2002–2025)
The table below shows the annual total assets of Getinge AB ser. B from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr56.51 Billion ≈ $6.08 Billion |
-11.60% |
| 2024-12-31 | Skr63.92 Billion ≈ $6.88 Billion |
+19.28% |
| 2023-12-31 | Skr53.59 Billion ≈ $5.77 Billion |
+2.99% |
| 2022-12-31 | Skr52.03 Billion ≈ $5.60 Billion |
+16.78% |
| 2021-12-31 | Skr44.55 Billion ≈ $4.79 Billion |
-1.02% |
| 2020-12-31 | Skr45.01 Billion ≈ $4.84 Billion |
+0.67% |
| 2019-12-31 | Skr44.71 Billion ≈ $4.81 Billion |
+3.14% |
| 2018-12-31 | Skr43.35 Billion ≈ $4.67 Billion |
+2.97% |
| 2017-12-31 | Skr42.10 Billion ≈ $4.53 Billion |
-23.74% |
| 2016-12-31 | Skr55.21 Billion ≈ $5.94 Billion |
+3.71% |
| 2015-12-31 | Skr53.23 Billion ≈ $5.73 Billion |
+0.79% |
| 2014-12-31 | Skr52.82 Billion ≈ $5.68 Billion |
+19.22% |
| 2013-12-31 | Skr44.30 Billion ≈ $4.77 Billion |
+3.22% |
| 2012-12-31 | Skr42.92 Billion ≈ $4.62 Billion |
+3.50% |
| 2011-12-31 | Skr41.47 Billion ≈ $4.46 Billion |
+19.90% |
| 2010-12-31 | Skr34.59 Billion ≈ $3.72 Billion |
-7.77% |
| 2009-12-31 | Skr37.50 Billion ≈ $4.04 Billion |
+13.52% |
| 2008-12-31 | Skr33.03 Billion ≈ $3.55 Billion |
+43.67% |
| 2007-12-31 | Skr22.99 Billion ≈ $2.47 Billion |
+44.81% |
| 2006-12-31 | Skr15.88 Billion ≈ $1.71 Billion |
+9.25% |
| 2005-12-31 | Skr14.53 Billion ≈ $1.56 Billion |
+16.66% |
| 2004-12-31 | Skr12.46 Billion ≈ $1.34 Billion |
+3.53% |
| 2003-12-31 | Skr12.03 Billion ≈ $1.29 Billion |
+26.95% |
| 2002-12-31 | Skr9.48 Billion ≈ $1.02 Billion |
-- |
About Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solu… Read more